Delivery Order SPE2DB25D3020-SPE2DB25FWKFA
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,707.63 for 60 tablets of Viberzi 100 mg, with a completion date of July 28, 2025. This competitively awarded, firm fixed-price contract represents a pediatric order from the pharmaceutical distributor's extensive portfolio of federal medical supply contracts. The contract was executed on July 25, 2025, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,707.63 to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product used to treat irritable bowel syndrome. This competitively awarded, firm fixed-price delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The award was performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, and represents a child contract under...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.26 to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count package). This firm fixed-price, competitively awarded delivery order was issued on August 7, 2025, with an ultimate completion date of August 8, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. The contract represents a continuation of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Viberzi 100 mg tablets (60-count) under a firm fixed-price contract valued at $1,734.24. This is a competitively awarded, non-set-aside delivery order with an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of VIBERZI 100 MG tablets (60-count units) valued at $1,138.42 under a firm fixed-price contract. This award, which carries an ultimate completion date of August 8, 2025, represents a child delivery order issued against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Viberzi 100 mg tablets (60-count units) with a ceiling value of $2,089.66. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside designation and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 60 tablets of the medication Viberzi 100 mg. The $4,161.11 firm fixed-price contract has a completion date of September 18, 2024. AmerisourceBergen has an extensive Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for delivering a range of medical commodities to military...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,674.47 contract is for the delivery of 60 tablets of the drug Viberzi 75 mg. The contract has a completion date of June 7, 2023 and was awarded on June 6, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Viberzi 100 mg tablets (60-count units) under a firm fixed price contract valued at $1,165.72. This non-set-aside delivery order, issued on July 31, 2025, with completion targeted for August 1, 2025, represents a routine pharmaceutical procurement through the agency's medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the prime contractor...
- The Defense Logistics Agency awarded a $3,689.52 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Viberzi 75 mg tablets (60-count packages). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 29, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKFADelivery Order
The Defense Logistics Agency awarded a $2,161.03 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Viberzi 100 mg, a pharmaceutical product for gastrointestinal treatment. This non-set-aside order was competitively awarded on August 22, 2025, with an ultimate completion date of August 25, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The company, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. AmerisourceBergen's Pharmaceutical Prime Vendor Global Program contract vehicle enables the company to supply a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency and other government healthcare systems worldwide. The firm fixed-price delivery order model with DLA reflects the company's established capability to fulfill federal medical supply requirements through open competition. This transaction exemplifies the operational efficiency of the IDC structure, allowing rapid procurement of specific pharmaceutical items as needed to support federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/22/25 |